Tatva Chintan Pharma Chem Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Chintan Shah
Chief Executive Officer (CEO)
₹13.4m
Compensación total
| Porcentaje del salario del CEO | 25.0% |
| Permanencia del CEO | 28.4yrs |
| Participación del CEO | 23.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 16.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues
Sep 26
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00
Aug 29Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%
Jul 27Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹176m |
| Jun 30 2024 | n/a | n/a | ₹261m |
| Mar 31 2024 | ₹13m | ₹3m | ₹304m |
| Dec 31 2023 | n/a | n/a | ₹377m |
| Sep 30 2023 | n/a | n/a | ₹459m |
| Jun 30 2023 | n/a | n/a | ₹452m |
| Mar 31 2023 | ₹17m | ₹5m | ₹455m |
| Dec 31 2022 | n/a | n/a | ₹460m |
| Sep 30 2022 | n/a | n/a | ₹572m |
| Jun 30 2022 | n/a | n/a | ₹825m |
| Mar 31 2022 | ₹17m | ₹5m | ₹959m |
| Dec 31 2021 | n/a | n/a | ₹995m |
| Sep 30 2021 | n/a | n/a | ₹976m |
| Jun 30 2021 | n/a | n/a | ₹687m |
| Mar 31 2021 | ₹14m | n/a | ₹523m |
| Mar 31 2020 | ₹14m | n/a | ₹378m |
| Mar 31 2019 | ₹14m | n/a | ₹205m |
Compensación vs. Mercado: La compensación total ($USD158.48K) de Chintan está en línea con el promedio de empresas de tamaño similar en el mercado Indian ($USD194.43K).
Compensación vs. Ingresos: La compensación de Chintan ha sido consistente con los resultados de la empresa en el último año.
CEO
Chintan Shah (51 yo)
28.4yrs
Permanencia
₹13,390,870
Compensación
Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 28.4yrs | ₹13.39m | 23.84% ₹ 4.5b | |
| Whole Time Director | 28.4yrs | ₹13.39m | 24.01% ₹ 4.5b | |
| Whole Time Director | 28.4yrs | ₹13.39m | 24% ₹ 4.5b | |
| Non Executive Independent Director | 3.8yrs | ₹265.00k | sin datos | |
| Non Executive Independent Director | 3.8yrs | ₹285.00k | sin datos | |
| Non Executive Independent Director | 3.8yrs | ₹22.50k | sin datos |
16.1yrs
Permanencia media
51.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de TATVA son experimentados ( 16.1 años antigüedad media).